Align Technology | ALGN - SCHULD

Aktienkurs
160.53
Täglich Wechseln
-1.22 -0.75%
Monatlich
-13.94%
Jährlich
-14.03%
Q2 Prognose
165.29




SCHULD Veränderung Datum
3M USD 12.56B 46M 2026-03
Align Technology USD 114.45M 6.82M 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Bruker USD 2.04B 34.4M 2025-12
Cardinal Health USD 8.92B 111M 2026-03
Charles River Laboratories USD 2.57B 58.23M 2025-12
Cooper Companies USD 2.51B 27M 2025-09
CVS Health USD 78.34B 13.78B 2026-03
Danaher USD 18.48B 66M 2026-03
Dentsply International USD 2.33B 137M 2026-03
Dexcom USD 1.24B 900K 2026-03
Henry Schein USD 3.75B 313M 2026-03
Idexx Laboratories USD 1.11B 129.39M 2026-03
Insulet USD 949.2M 65.6M 2025-12
Integra LifeSciences USD 2.04B 6.27M 2026-03
IQVIA Holdings USD 15.83B 109M 2026-03
Masimo USD 485.9M 100.3M 2026-03
McKesson USD 8.62B 1.17B 2025-12
Mettler Toledo International USD 2.15B 57.69M 2025-12
Revvity USD 3.4B 29.2M 2025-12
Solventum Corp USD 7.91B 97M 2025-03
Stryker USD 14.22B 635M 2026-03
Teleflex USD 2.73B 43.5M 2025-12
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Veeva Systems USD 89.8M 4.35M 2025-09
Waters USD 1.49B 4.92M 2025-12
Zimmer Biomet Holdings USD 7.47B 48.1M 2026-03
Zoetis USD 9.24B 1.96B 2025-12